Garo Armen

Track

Insider profile

Currently holds positions in Protagenic Therapeutics Inc and Agenus Inc

Performance

Overall performance
2.4
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 34% 8.2% 15.1%
Success rate 80% 68% 82%
Transactions
5 80% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -79%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance

Positions

Position Company Period
Chairman of the Board Protagenic Therapeutics Inc Feb. 12, 2016 -
Chairman of the Board, Chief Executive Officer, Co-Founder Agenus Inc Jan. 1, 1994 -
Garo Armen's trades of Protagenic Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-06 2026-08-05
B Purchase
28,606 -15.3%
448.41
US$1,515,293 		28,606 -15.3% 448.41 US$1,515,293
2026-08-03 2026-07-30
B Purchase
5,485 +9.2%
19.77
US$164,145 		5,485 +9.2% 19.77 US$164,145
2024-02-15 2024-02-15
US Agenus Inc (AGEN)
B Purchase
86,180 -41.7%
24.25
US$4,896,087 		86,180 -41.7% 24.25 US$4,896,087
2023-05-05 2023-05-05
S Sale
100,000 -5.1%
0.95
US$94,850 		100,000 -5.1% 0.95 US$94,850
2023-05-04 2023-05-02
B Purchase
100,000 +5.3%
0.95
US$94,850 		100,000 +5.3% 0.95 US$94,850
2021-09-14 2021-09-13
US Agenus Inc (AGEN)
S Sale
82,107 -9.6%
6.50
US$533,696 		82,107 -9.6% 6.50 US$533,696
2004-10-28 2004-10-27
US Agenus Inc (AGEN)
B Purchase
25,000 +0.2%
6.39
US$159,760 		25,000 +0.2% 6.39 US$159,760
2004-10-21 2004-10-21
US Agenus Inc (AGEN)
B Purchase
100,000 +0.9%
4.74
US$474,300 		100,000 +0.9% 4.74 US$474,300